Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€127.20

€127.20

-3.820%
-5.1
-3.820%
-
 
31.05.24 / Tradegate WKN: A2G9K9 / Name: Reply / Stock / Software & IT Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Reply SpA Stock

Heavy losses for Reply SpA today as the stock fell by -€5.100 (-3.820%).

Pros and Cons of Reply SpA in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Reply SpA vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Reply SpA -3.820% -6.813% 2.581% 25.444% 6.444% -3.196% -
Txt E-Solutions -0.850% 0.212% 12.619% 12.352% 21.407% 202.430% -
Exprivia 1.250% -3.614% -2.736% 24.031% -2.439% 39.738% -
Digital Turbine Inc. -1.480% -11.201% -2.145% -79.438% -72.541% -96.763% -

News

EQS-News: Reply: The Board of Directors approves the quarterly report dated 31 March 2024: https://mms.businesswire.com/media/20200310005095/en/778528/5/bg.jpg
EQS-News: Reply: The Board of Directors approves the quarterly report dated 31 March 2024
EQS-News: Reply: The Board of Directors approves the quarterly report dated 31 March 2024
REPLY S.p.A.: Shareholders’ Meeting Approves the 2023 Financial Statements: https://mms.businesswire.com/media/20200310005095/en/778528/5/bg.jpg
REPLY S.p.A.: Shareholders’ Meeting Approves the 2023 Financial Statements


The General Shareholders’ meeting of Reply S.p.A. [EXM, STAR: REY] today approved the Financial Statements for the financial year 2023, confirming the distribution of a gross dividend of €1.00 per

REPLY: Value Based Medicine Is Born, the Platform Created by Laife Reply for IEO That Makes Patient Care Increasingly Personalised and Appropriate: https://mms.businesswire.com/media/20200310005095/en/778528/5/bg.jpg
REPLY: Value Based Medicine Is Born, the Platform Created by Laife Reply for IEO That Makes Patient Care Increasingly Personalised and Appropriate


Laife Reply, a company within the Reply Group focused on using AI, Big Data and Machine Learning to innovate preventive healthcare and treatment processes has developed, in collaboration with IEO